#Switzerland #Geneva #Bridge to Life #organ preservation #ILTS Congress

Bridge to Life Announces Presentations at 2026 ILTS Congress

Bridge to Life™ Ltd., a global leader in organ preservation solutions and perfusion technology, has announced its participation at the 2026 International Liver Transplantation Society (ILTS) Congress, to be held in Geneva, Switzerland, from May 6 to 9, 2026. The company will showcase innovative techniques and research findings that aim to enhance the success of liver transplants.

Presentations Overview

The company is set to present a total of 12 accepted abstracts at the Congress, including five oral presentations—one of which is a plenary session—and seven poster presentations. This conference, regarded as a premier gathering in the field of liver transplantation, will focus on recent advancements and clinical practices that improve organ preservation.

Some highlights include:

• - Spender Serum-FMN as a Predictor: An oral presentation discussing how donor serum levels might indicate mitochondrial damage and predict outcomes post-liver transplantation.
• - Prolonged Hypothermic Oxygenated Perfusion (HOPE): Another significant presentation will explore how HOPE retains mitochondrial function and provides logistical flexibility during liver transplants.

These presentations will be delivered by leading experts from acclaimed institutions, including the Cleveland Clinic, and are intended to provide critical insights into organ transplant methodologies.

Poster Presentations

Amidst the array of engaging sessions, several poster presentations will also take place. Noteworthy abstracts include:

• - Sequential Normothermic Regional Perfusion: Investigating how this technique can protect against ischemic cholangiopathy after transplantation.
• - HOPE in Expanding Donor Acceptance Criteria: A multicenter matched-cohort study illustrating how hypothermic perfusion allows for better donor acceptance without compromising transplant outcomes.

These presentations reflect a commitment to improving liver transplant success rates, particularly for pediatric patients and those receiving partial grafts.

Symposium Sponsorship

In addition to its presentations, Bridge to Life will sponsor a lunch symposium titled "The Future of Machine Perfusion: Combining Strategies, Optimizing Care, and Expanding Possibilities." This event is scheduled for May 7, and promises to feature discussions from notable experts in the field, including Damiano Patrono, Rebeca Mateos, and Andrea Schlegel.

About Bridge to Life™ Ltd

Bridge to Life is renowned for its innovative organ preservation products, including the Belzer UW®, EasiSlush®, and the VitaSmart™ Hypothermic Oxygenated Perfusion System. The company places strong emphasis on innovation and quality, collaborating with leading transplant centers and organ procurement organizations globally.

For further information and updates regarding the conference, please visit the ILTS Congress website or Bridge to Life’s official channels.

This event is expected to make significant contributions to the ongoing dialogue within the organ transplantation community, ensuring advancements in both techniques and patient outcomes as the industry continues to evolve.